Instrumento Inactivo

Otros idiomas Oxford Immunotec Global PLC

Acciones

OXFD

GB00BGFBB958

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Oxford Immunotec Announces Use of T-SPOT®Discovery SARS-CoV-2 Kit	29/04/21
Oxford Immunotec Global PLC will Change its Name to Oxford Immunotec Global Limited	09/03/21
Oxford Immunotec Global PLC Announces Board Changes	08/03/21
Oxford Immunotec Global PLC(NasdaqGM:OXFD) dropped from S&P Global BMI Index	08/03/21
Oxford Immunotec Global PLC(NasdaqGM:OXFD) dropped from NASDAQ Composite Index	08/03/21
PerkinElmer (UK) Holdings Limited completed the acquisition of Oxford Immunotec Global PLC.	08/03/21
Oxford Immunotec Global PLC's Equity Buyback announced on January 7, 2019, has expired.	08/03/21
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection	04/03/21
Oxford Immunotec Global : Plans to Market T Cell Immune Response Measurement Kit to COVID-19 in South Korea	08/02/21
Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea	08/02/21
Oxford Immunotec Global PLC Enters into A Memorandum of Understanding Green Cross Medical Science Corp. to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea	08/02/21
Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses	04/02/21
Oxford Immunotec Updates Their T-SPOT® Discovery SARS-Cov-2 Kit and Include New Panel to Detect T Cells Reactive to Endemic Coronaviruses	04/02/21
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19	14/01/21
OXFORD IMMUNOTEC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oxford Immunotec Global PLC - OXFD	14/01/21
Oxford Immunotec Global : Teams With Valneva on COVID-19 Vaccine Candidate Testing	13/01/21
Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study	13/01/21
Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study	13/01/21
Sector Update: Health Care Stocks Add to Early Rise, Supported by Biotech Companies	07/01/21
Sector Update: Modest Advance for Health Care Stocks Despite Larger Gains for Biotechnology Sector	07/01/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Oxford Immunotec Global PLC

Acciones

OXFD

GB00BGFBB958

Otros idiomas

Filtros